Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan J Chipman

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Statistics in Medicine|July 13, 2023
Rematching on-the-fly: Sequential matched randomization and a case for covariate-adjusted randomizationJonathan J Chipman, Lindsay Mayberry, Robert A Greevy
The American Statistician|February 27, 2025
Sequential monitoring using the Second Generation P-Value with Type I error controlled by monitoring frequencyJonathan J Chipman, Robert A Greevy, Lindsay Mayberry, et al.
JCO Precision Oncology|December 3, 2024
Multigene Copy Number Alteration Risk Score Biomarker-Based Enrichment Study Designs in Metastatic Castrate-Resistant Prostate CancerYeonjung Jo, Jonathan J Chipman, Benjamin Haaland, et al.
BMC Medical Research Methodology|November 4, 2025
Current practice on covariate adjustment and stratified analysis -based on survey results by ASA oncology estimand working group conditional and marginal effect task forceJiawei Wei, Sarwar I Mozumder, Liming Li, et al.
Practical Radiation Oncology|June 25, 2018
Predicting erectile function following external beam radiation therapy or brachytherapy for prostate cancer using EPIC-CPStephen A Mihalcik, Jonathan J Chipman, Martin G Sanda, et al.
The Journal of Urology|October 1, 2013
Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practiceJonathan J Chipman, Martin G Sanda, Rodney L Dunn, et al.
Cancer Medicine|February 22, 2023
Secondary malignancies in non-Hodgkin lymphoma survivors: 40 years of follow-up assessed by treatment modalityMatthew W Parsons, Calvin Rock, Jonathan J Chipman, et al.
Clinical Lung Cancer|November 21, 2024
Augmenting Prognostication: Utilizing Activity Trackers to Enhance Survival Prediction in Metastatic Non-Small Cell Lung CancerYeonjung Jo, Sonam Puri, Benjamin Haaland, et al.
Advances in Radiation Oncology|November 24, 2022
Second Primary Malignancies in Diffuse Large B-cell Lymphoma Survivors with 40 Years of Follow Up: Influence of Chemotherapy and Radiation TherapyCalvin B Rock, Jonathan J Chipman, Matthew W Parsons, et al.
BMC Medical Research Methodology|August 17, 2021
A roadmap to using randomization in clinical trialsVance W Berger, Louis Joseph Bour, Kerstine Carter, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Statistics in Medicine|July 13, 2023
Rematching on-the-fly: Sequential matched randomization and a case for covariate-adjusted randomizationJonathan J Chipman, Lindsay Mayberry, Robert A Greevy
The American Statistician|February 27, 2025
Sequential monitoring using the Second Generation P-Value with Type I error controlled by monitoring frequencyJonathan J Chipman, Robert A Greevy, Lindsay Mayberry, et al.
JCO Precision Oncology|December 3, 2024
Multigene Copy Number Alteration Risk Score Biomarker-Based Enrichment Study Designs in Metastatic Castrate-Resistant Prostate CancerYeonjung Jo, Jonathan J Chipman, Benjamin Haaland, et al.
BMC Medical Research Methodology|November 4, 2025
Current practice on covariate adjustment and stratified analysis -based on survey results by ASA oncology estimand working group conditional and marginal effect task forceJiawei Wei, Sarwar I Mozumder, Liming Li, et al.
Practical Radiation Oncology|June 25, 2018
Predicting erectile function following external beam radiation therapy or brachytherapy for prostate cancer using EPIC-CPStephen A Mihalcik, Jonathan J Chipman, Martin G Sanda, et al.
The Journal of Urology|October 1, 2013
Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practiceJonathan J Chipman, Martin G Sanda, Rodney L Dunn, et al.
Cancer Medicine|February 22, 2023
Secondary malignancies in non-Hodgkin lymphoma survivors: 40 years of follow-up assessed by treatment modalityMatthew W Parsons, Calvin Rock, Jonathan J Chipman, et al.
Clinical Lung Cancer|November 21, 2024
Augmenting Prognostication: Utilizing Activity Trackers to Enhance Survival Prediction in Metastatic Non-Small Cell Lung CancerYeonjung Jo, Sonam Puri, Benjamin Haaland, et al.
Advances in Radiation Oncology|November 24, 2022
Second Primary Malignancies in Diffuse Large B-cell Lymphoma Survivors with 40 Years of Follow Up: Influence of Chemotherapy and Radiation TherapyCalvin B Rock, Jonathan J Chipman, Matthew W Parsons, et al.
BMC Medical Research Methodology|August 17, 2021
A roadmap to using randomization in clinical trialsVance W Berger, Louis Joseph Bour, Kerstine Carter, et al.
Pageof 2